Penn Davis McFarland
ABBV icon

Penn Davis McFarland’s AbbVie ABBV Stock Holding History

Penn Davis McFarland’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8M Sell
30,580
-50
-0.2% -$12.8K 0.68% 31
2026
Q2 		$7.71M Buy
30,630
+166
+0.5% +$35.7K 0.69% 31
2026
Q1 		$6.63M Hold
30,464
– – 0.65% 31
2025
Q4 		$6.96M Sell
30,464
-50
-0.2% -$11.4K 0.67% 29
2025
Q3 		$7.07M Hold
30,514
– – 0.73% 28
2025
Q2 		$5.66M Sell
30,514
-50
-0.2% -$9.29K 0.64% 30
2025
Q1 		$6.4M Sell
30,564
-80
-0.3% -$15.6K 0.76% 29
2024
Q4 		$5.45M Sell
30,644
-298
-1% -$54.8K 0.59% 30
2024
Q3 		$6.11M Buy
+30,942
New +$5.77M 0.69% 32

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Penn Davis McFarland's ABBV Position: Q3 2026 in Review

Penn Davis McFarland reduced its AbbVie (ABBV) stake by 0.16% in Q3 2026, selling an estimated $12.8K and leaving 30,580 shares worth $8M. The position accounts for 0.68% of the portfolio, ranked #31.

Penn Davis McFarland first reported a position in ABBV in Q3 2024 and has held it in 9 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Penn Davis McFarland held 30,580 shares of AbbVie worth $8M as of Q3 2026.
  • Penn Davis McFarland sold 50 AbbVie shares in Q3 2026, an estimated $12.8K.
  • AbbVie made up 0.68% of Penn Davis McFarland's portfolio in Q3 2026, its #31 holding.
  • Penn Davis McFarland first reported a position in AbbVie in Q3 2024 and has held it in 9 quarters since.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Penn Davis McFarland's 13F filing for Q3 2026, filed 23 Oct 2026.